Wednesday, April 24, 2024
Canada’s Politics and Government News Source Since 1989
Wednesday, April 24, 2024 | Latest Paper

Marc-André Gagnon

Marc-André Gagnon, PhD, is an associate professor in the school of public policy and administration at Carleton University.

Opinion | BY MARC-ANDRé GAGNON | February 4, 2019
Among all OECD countries, Canada ends up with the highest prices for patented drugs, behind the United States and Switzerland. We pay on average 25 per cent more on the price of patented drugs as compared to the median of OECD countries in the hope to attract investment in research and development (R&D), writes Marc-André Gagnon. Image courtesy of Pixabay
Opinion | BY MARC-ANDRé GAGNON | February 4, 2019
Opinion | BY MARC-ANDRé GAGNON | February 4, 2019
Among all OECD countries, Canada ends up with the highest prices for patented drugs, behind the United States and Switzerland. We pay on average 25 per cent more on the price of patented drugs as compared to the median of OECD countries in the hope to attract investment in research and development (R&D), writes Marc-André Gagnon. Image courtesy of Pixabay